Forefront Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Forefront Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$632K	Buy	1,260 +12	+1%	+$5.76K	0.2%	103
2026 Q1	$614K	Buy	1,248 +104	+9%	+$56.4K	0.26%	86
2025 Q4	$663K	Sell	1,144 -243	-18%	-$137K	0.31%	70
2025 Q3	$673K	Buy	1,387 +480	+53%	+$223K	0.17%	106
2025 Q2	$472K	Sell	907 -83	-8%	-$34.7K	0.32%	62
2025 Q1	$493K	Buy	990 +83	+9%	+$45K	0.34%	70
2024 Q4	$472K	Buy	+907	New	+$499K	0.35%	60

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Forefront Wealth Partners's TMO Position: Q2 2026 in Review

Forefront Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 0.96% in Q2 2026, buying an estimated $5.76K and bringing the position to 1,260 shares worth $632K. The position accounts for 0.2% of the portfolio, ranked #103.

Forefront Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $673K in Q3 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Forefront Wealth Partners held 1,260 shares of Thermo Fisher Scientific worth $632K as of Q2 2026.
Forefront Wealth Partners bought 12 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.76K.
Thermo Fisher Scientific made up 0.2% of Forefront Wealth Partners's portfolio in Q2 2026, its #103 holding.
Forefront Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Forefront Wealth Partners's Thermo Fisher Scientific position peaked at $673K in Q3 2025.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Forefront Wealth Partners's 13F filing for Q2 2026, filed 20 Aug 2026.